Articles > Blood Cancer

  1. Ushering In a New Era of Pediatric Blood Cancer Treatment and Care

    We caught up with Gwen Nichols, MD, Chief Medical Officer at The Leukemia & Lymphoma Society (LLS), to share the progress we’re making to bring cures and better care to children with blood cancer through The LLS Children’s Initiative. Tell us about The LLS Children’s Initiative and why it’s so important to you and LLS. When I joined LLS in the spring of 2017, I knew my first order of business would be advancing our work for pediatric blood cancers. As a physician and re...

    Read More
  1. Helping Blood Cancer Patients and Families When It's Needed Most

    In honor of Blood Cancer Awareness Month, Dr. Gwen Nichols reflects on our vital work to support blood cancer patients and their families. As Chief Medical Officer of The Leukemia & Lymphoma Society (LLS), I often speak with patients and survivors about adjusting to their new normal after a cancer diagnosis or treatment. But finding a new normal looks very different in a world where a global pandemic has impacted every aspect of cancer care and daily life as we know it. COVID-19 is res...

    Read More
  2. FDA Approves New Maintenance Treatment for AML

    Some promising news to kick off Blood Cancer Awareness Month – on September 1, 2020, the U.S. Food and Drug Administration approved a new oral maintenance treatment for certain adult patients with acute myeloid leukemia (AML). CC-486 (Onureg®) is now approved for the continued treatment of adult patients with AML who achieved first complete remission (CR) or CR with incomplete blood count recovery (Cri) following intensive induction chemotherapy and who are not able to undergo intensive...

    Read More
  3. Striving for Social Justice, Racial Equality and Diversity

    As a patient focused organization, we stand for: All cancer patients, working to ensure they have access to quality affordable care. Racial justice and equality for Black people. Diversity and inclusion among our staff and volunteers. We stand against hate, prejudice and injustice. Along with you, we watched in horror the death of George Floyd and we feel outrage at the injustice it represents. As we witness nightly disturbing images of violence and unrest in our ...

    Read More
  1. #ASCO20: Cancer in the Time of COVID-19, and Progress in Myeloma and Lymphoma

    As National Cancer Research Month (May) winds down, it seems timely to reflect on progress in cancer treatments. And that is precisely what we will do this weekend. This is the weekend Chicago would typically be flooded with more than 40,000 researchers, clinicians, pharmaceutical company reps, media and cancer advocacy organizations as the annual host of the world’s biggest cancer conference. But like all other large events around the globe, the American Society of Clinical Oncology...

    Read More
  2. AACR 2020 Goes Virtual

    The American Association of Clinical Research, like so many other organizations, was forced to move its major annual meeting from sunny San Diego to a virtual format this past week in response to the COVID-19 pandemic. AACR made the decision to host the meeting on a virtual platform over two days to give scientists an opportunity to present their latest discoveries across the spectrum of cancer research. Several presentations relevant to the blood cancers drew my interest. Off-the-s...

    Read More
  3. Recent Drug Approvals for Blood Cancer Mark Significant Progress for Patients

    Driving forward science While we all are navigating uncertainty and challenges in these unprecedented times, there is promising news: science is racing forward. Dedicated researchers around the world are collaborating in new ways, sharing data openly and advancing our understanding of the novel virus that causes coronavirus disease (COVID-19). In fact, more than 70 countries have joined the World Health Organization in accelerating research on effective treatments for COVID-19 and about 20...

    Read More
  4. Harnessing the Power of Women

    “Women have the power and when we join together, we can make all the difference.” With those words, Stephanie McMahon, Chief Brand Officer at WWE, captured the theme of The Leukemia & Lymphoma Society’s (LLS) “Women Curing Cancer” initiative, which brings together philanthropic women to move collectively the needle in cancer cures and access to treatments. On Wednesday, Stephanie joined LLS’s Chief Medical Officer Dr. Gwen Nichols, and LLS volunteer Julie Guillot, ...

    Read More
  5. Families Fighting for Cancer Cures: Generation LLS

    As an organization founded by a family for families, The Leukemia & Lymphoma Society (LLS) is celebrating 70 years of impact on generations of families, researchers and volunteers while looking to the future by redoubling its commitment to improve treatments and care for children with cancer. To accomplish its bold vision for children, LLS is launching The LLS Children’s Initiative to deliver cures and care for children by disrupting drug development for pediatric cancers and ex...

    Read More
  6. Less Is More and Don’t Eat Me! (#ASCO18)

    This post is one in a series of news updates from ASCO. Read more by clicking here and here. The American Society of Clinical Oncology (#ASCO18) annual meeting is an opportunity to show the progress on investigational cancer therapies, better ways to use old medicines and improved methods of diagnosis. One of the interesting themes to emerge over the past few days here in Chicago is the goal of giving less rather than more treatment. The quest to de-escalate treatment helps avoid bo...

    Read More